An update on actively targeted liposomes in advanced drug delivery to glioma

S Mojarad-Jabali, M Farshbaf, PR Walker… - International Journal of …, 2021 - Elsevier
High-grade glioma is one of the most aggressive types of cancer with a low survival rate
ranging from 12 to 15 months after the first diagnosis. Though being the most common …

Recent advancements in liposome-targeting strategies for the treatment of gliomas: a systematic review

J Li, T Tan, L Zhao, M Liu, Y You, Y Zeng… - ACS Applied Bio …, 2020 - ACS Publications
Malignant tumors represent some of the most intractable diseases that endanger human
health. A glioma is a tumor of the central nervous system that is characterized by severe …

Liposome-based glioma targeted drug delivery enabled by stable peptide ligands

X Wei, J Gao, C Zhan, C Xie, Z Chai, D Ran… - Journal of Controlled …, 2015 - Elsevier
The treatment of glioma is one of the most challenging tasks in clinic. As an intracranial
tumor, glioma exhibits many distinctive characteristics from other tumors. In particular …

Strategies for liposome drug delivery systems to improve tumor treatment efficacy

J Wang, J Gong, Z Wei - Aaps Pharmscitech, 2022 - Springer
In the advancement of tumor therapy, in addition to the search for new antitumor
compounds, the development of nano-drug delivery systems has opened up new pathways …

Recent advances in liposome-based targeted cancer therapy

Y Fidan, S Muçaj, SS Timur… - Journal of Liposome …, 2024 - Taylor & Francis
Nano-drug delivery systems have opened new pathways for tumor treatment by overcoming
some of the limitations of conventional drugs, such as physiological degradation, short half …

Liposomes for tumor targeted therapy: a review

S Wang, Y Chen, J Guo, Q Huang - International journal of molecular …, 2023 - mdpi.com
Liposomes, the most widely studied nano-drug carriers in drug delivery, are sphere-shaped
vesicles consisting of one or more phospholipid bilayers. Compared with traditional drug …

Updates on the use of liposomes for active tumor targeting in cancer therapy

W Yan, SSY Leung, KKW To - Nanomedicine, 2020 - Taylor & Francis
In the development of cancer chemotherapy, besides the discovery of new anticancer drugs,
a variety of nanocarrier systems for the delivery of previously developed and new …

Functionalized liposomes as drug nanocarriers for active targeted cancer therapy: a systematic review

H Abbasi, N Rahbar, M Kouchak… - Journal of liposome …, 2022 - Taylor & Francis
Cancer is a broad term used to describe a group of diseases that have more than 270 types.
Today, due to the suffering of patients from the side effects of existing methods in the …

Liposomes for the treatment of brain cancer—A review

R Raju, WH Abuwatfa, WG Pitt, GA Husseini - Pharmaceuticals, 2023 - mdpi.com
Due to their biocompatibility, non-toxicity, and surface-conjugation capabilities, liposomes
are effective nanocarriers that can encapsulate chemotherapeutic drugs and facilitate …

Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice?

S Fathi, AK Oyelere - Future medicinal chemistry, 2016 - Taylor & Francis
Liposomes are biodegradable and biocompatible self-forming spherical lipid bilayer
vesicles. They can encapsulate and deliver one or more hydrophobic and hydrophilic …